Stress bleeding prophylaxis with sucralfate. Pathophysiologic basis and clinical use.

Area of Science:

• Critical Care Medicine
• Gastroenterology
• Pharmacology

Background:

• Acute stress bleeding in intensive care is multifactorial, stemming from an imbalance between aggressive and protective gastric factors.
• Patients in intensive care often exhibit reduced gastric acid secretion, diminished mucosal blood flow, and decreased mucus and bicarbonate production.
• These physiological changes create a vulnerable gastric environment susceptible to stress-induced injury.

Purpose of the Study:

• To elucidate the pathophysiological basis for sucralfate's efficacy in preventing stress bleeding in intensive care patients.
• To compare the effects of sucralfate with alkalinizing agents (antacids, H2-antagonists) on gastric physiology and patient outcomes.
• To define the indications and limitations of sucralfate in the prophylaxis of stress bleeding.

Main Methods:

• Review of pathophysiological mechanisms underlying stress bleeding in intensive care.
• Analysis of sucralfate's pharmacological actions on gastric defense mechanisms.
• Comparative assessment of sucralfate versus alkalinizing drugs regarding gastric pH, bacterial overgrowth, and mortality rates.

Main Results:

• Sucralfate enhances gastric protective factors, including mucus and bicarbonate secretion, and improves mucosal blood flow.
• Unlike alkalinizing drugs, sucralfate has minimal impact on gastric pH, thereby reducing bacterial overgrowth.
• Sucralfate demonstrated significant bactericidal effects, contributing to reduced gastric and gut bacterial proliferation.

Conclusions:

• Sucralfate's enhancement of mucosal defense mechanisms provides a strong pathophysiological basis for its effectiveness in preventing stress bleeding.
• The distinct mechanism of action, particularly its limited effect on gastric pH and bactericidal properties, differentiates sucralfate from alkalinizing agents.
• Sucralfate offers a valuable therapeutic option for stress bleeding prophylaxis in intensive care, with specific indications and limitations that warrant consideration.